All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know ALL.
To help navigate the exciting content being presented at the ASH2021 Virtual Congress, the ALL Hub Steering Committee members have provided their recommendations for the top abstracts to look out for in ALL, including both clinical content and disease biology sessions.
ASH2021 abstracts: What’s hot in ALL?
If you would like to view the top abstracts to look out for in ALL at ASH2021, please download the resource below.Download here
Your opinion matters
Progress in CAR-T therapy for T-ALL
In contrast to options for B-cell acute lymphoblastic leukemia, chimeric antigen receptor (CAR) T-cell therapy for T-cell acute lymphoblastic leukemia (T-ALL) is still in its initial stages, owing to difficulties...
Frontline treatments for older patients with Ph− B-ALL
Acute lymphoblastic leukemia (ALL) represents 5% of all newly diagnosed leukemias in older patients aged 55 to 70 years old. With recent advances largely centered around the younger population,...
Subscribe to get the best content related to ALL delivered to your inbox